ATE536873T1 - Feste orale formen von ebastin - Google Patents

Feste orale formen von ebastin

Info

Publication number: ATE536873T1
Authority: AT; Austria
Prior art keywords: solid oral; ebastin; oral forms; ebastine; relates
Prior art date: 2005-11-04

Application number

AT06830886T

Other languages

English (en)

Inventor

Millan Jordi Roma

Castell Jose Mestre

Negre Jose M Sune

Original Assignee

Simbec Iberica Sl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-04

Filing date

2006-10-20

Publication date

2011-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38005462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE536873(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-20 Application filed by Simbec Iberica Sl filed Critical Simbec Iberica Sl

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE536873T1 publication Critical patent/ATE536873T1/de

Links

MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 title abstract 3
229960001971 ebastine Drugs 0.000 title abstract 3
239000007787 solid Substances 0.000 title abstract 3
239000006185 dispersion Substances 0.000 abstract 1
230000008018 melting Effects 0.000 abstract 1
238000002844 melting Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000002736 nonionic surfactant Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT06830886T 2005-11-04 2006-10-20 Feste orale formen von ebastin ATE536873T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200502686A ES2277767B1 (es)	2005-11-04	2005-11-04	Formas orales solidas de ebastina.
PCT/ES2006/000581 WO2007051877A1 (es)	2005-11-04	2006-10-20	Formas orales sólidas de ebastina

Publications (1)

Publication Number	Publication Date
ATE536873T1 true ATE536873T1 (de)	2011-12-15

Family

ID=38005462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06830886T ATE536873T1 (de)	2005-11-04	2006-10-20	Feste orale formen von ebastin

Country Status (6)

Country	Link
US (1)	US20090304791A1 (de)
EP (1)	EP1944028B1 (de)
AT (1)	ATE536873T1 (de)
ES (2)	ES2277767B1 (de)
PT (1)	PT1944028E (de)
WO (1)	WO2007051877A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201113266A (en) *	2009-09-02	2011-04-16	Ziopharm Oncology Inc	Pharmaceutical formulations for indibulin
ES2606148T3 (es)	2011-11-01	2017-03-22	Inopharm Limited	Composición de disgregación oral de agentes antihistamínicos
CN105326802A (zh) *	2015-09-01	2016-02-17	杭州澳医保灵药业有限公司	一种依巴斯汀分散片及其制备方法
CN113784711A (zh) *	2019-03-12	2021-12-10	伊登布里奇制药有限公司	包含格隆溴铵的口崩片剂和提高生物利用度的方法
CN114712322A (zh) *	2022-04-01	2022-07-08	南京联智医药科技有限公司	一种依巴斯汀的盐的片剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2684298B1 (fr) *	1991-12-03	1994-03-11	Rhone Poulenc Rorer Sa	Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
ATE232087T1 (de) *	1997-10-27	2003-02-15	Merck Patent Gmbh	Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
US20030026834A1 (en) *	2001-04-10	2003-02-06	Fahkreddin Jamali	NSAIDs composition containing tartaric acid
WO2004069157A2 (en) *	2003-01-17	2004-08-19	Ophthalmic Research Associates, Inc.	Combinational use of long-acting and short-acting anti-histamines for ocular allergies
EP1750717B1 (de) *	2004-02-11	2017-07-19	Rubicon Research Private Limited	Pharmazeutische zusammensetzungen mit kontrollierter freisetzung und verbesserter bioverfügbarkeit

2005
- 2005-11-04 ES ES200502686A patent/ES2277767B1/es not_active Expired - Fee Related
2006
- 2006-10-20 PT PT06830886T patent/PT1944028E/pt unknown
- 2006-10-20 AT AT06830886T patent/ATE536873T1/de active
- 2006-10-20 EP EP06830886A patent/EP1944028B1/de active Active
- 2006-10-20 WO PCT/ES2006/000581 patent/WO2007051877A1/es not_active Ceased
- 2006-10-20 ES ES06830886T patent/ES2380229T3/es active Active
- 2006-10-20 US US12/092,477 patent/US20090304791A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1944028B1 (de)	2011-12-14
ES2380229T3 (es)	2012-05-09
WO2007051877A1 (es)	2007-05-10
EP1944028A1 (de)	2008-07-16
ES2277767B1 (es)	2008-04-01
PT1944028E (pt)	2012-03-22
ES2277767A1 (es)	2007-07-16
US20090304791A1 (en)	2009-12-10

Similar Documents

Publication	Publication Date	Title
DE60305861D1 (de)	2006-07-20	Reinigungsmittelzusammensetzungen
DE602006010979D1 (de)	2010-01-21	Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
CY1117164T1 (el)	2017-04-05	Φαρμακευτικες συνθεσεις περιλαμβανουσες κολλοειδες διοξειδιο πυριτιου
NO20074087L (no)	2007-10-09	Oralt disintegrert sammensetning av olanzapin eller donepezil
CY1112401T1 (el)	2015-12-09	Παραγωγα πυριδαζινης
DE602006013493D1 (de)	2010-05-20	Oxadiazolylpyrazolopyrimidine als mglur2-antagonisten
ITRM20010464A1 (it)	2003-01-31	Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
NO20071476L (no)	2007-03-19	Antidiuretiske midler.
PL375874A1 (pl)	2005-12-12	Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
NO20080122L (no)	2008-01-08	Blanding av diisononylestere av 1,2syklodikarbonsyrer, fremgangsmate for dere fremstilling og anvendelse derav
NO20034230D0 (no)	2003-09-23	1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
DE502006001198D1 (de)	2008-09-04	Veresterte alkylalkoxylate als schaumarme tenside
CY1113257T1 (el)	2016-04-13	Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων
MX2007010414A (es)	2007-09-25	Derivados de piridin-2-carboxamida como antagonistas de mglur5.
WO2006100081A3 (de)	2006-12-07	Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
WO2007071915A3 (en)	2007-09-13	Pharmaceutical product comprising porous silicon
ATE400637T1 (de)	2008-07-15	Waschmittelzusammensetzung enthaltend mono- anionisches tensid
ATE536873T1 (de)	2011-12-15	Feste orale formen von ebastin
WO2007011878A3 (en)	2007-09-07	Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
DK1808165T3 (da)	2009-08-03	Törre formuleringer af aripiprazol
UA90130C2 (ru)	2010-04-12	Аморфный лерканидипина гидрохлорид и фармацевтическая композиция на его основе
MXPA04005497A (es)	2004-10-11	Composiciones nanoparticuladas de isotretinoin.
BR0003766A (pt)	2001-04-03	Misturas de tensoativos compreendendo ácido graxo n-alquilpolihidroxiamidas e ácido graxo amidoalcoxilatos
TNSN03065A1 (en)	2005-04-08	BIOPESTICIDE COMPOSITIONS
NO20075766L (no)	2007-11-09	Aminoalkyl-amidometyl-substituerte 2-(4-sulfonylamino)-3-hydroksy-3,4-dihydro-2H-kromen-6-yl-derivater og deres anvendelse som kaliumkanalblokkere